These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6315087)

  • 1. [The process of cyclic adenosine-3',5'-monophosphate phosphodiesterase activation by 2',5'-oligoadenylate].
    Tunitskaia VL; Itkes AV; Kochetkova MN; Severin ES
    Biokhimiia; 1983 Oct; 48(10):1721-5. PubMed ID: 6315087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
    Sobolev AS; Rybalkin SD
    Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells.
    Manganiello VC; Reed BC; Lieberman FS; Moss J; Lane MD; Vaughan M
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):143-54. PubMed ID: 6196386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on the relationship between the interferon enzyme system and the system of cyclic nucleotide metabolism.
    Kafiani CA; Itkes AV; Kartasheva ON; Kochetkova MN; Turpaev KT; Severin ES
    Adv Enzyme Regul; 1983; 21():353-65. PubMed ID: 6085824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterase activity in patients with obstructive airways disease.
    Polson JB; Krzanowski JJ; Goldman AL; Szentivanyi A
    Allergol Immunopathol (Madr); 1982; 10(2):101-4. PubMed ID: 6125092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotide derivatives as probes of phosphodiesterase catalytic and regulatory sites.
    Erneux C; Couchie D; Dumont JE; Jastorff B
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():107-18. PubMed ID: 6326517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a human melanoma cell line (KHm-1) containing phosphodiesterase activity only for cyclic adenosine 3':5'-monophosphate.
    King LE; Solomon SS; Hashimoto K
    Cancer Res; 1978 Nov; 38(11 Pt 1):3879-85. PubMed ID: 29705
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiple forms of cyclic nucleotide phosphotransferases in mouse thymocytes].
    Rybalkin SD; Kurennaia GS; Sobolev AS
    Biokhimiia; 1984 Dec; 49(12):1927-33. PubMed ID: 6098315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Properties of cyclic nucleotide phosphodiesterase from lingual taste papillae].
    Ostretsova IB
    Biokhimiia; 1978 Jun; 43(6):1037-44. PubMed ID: 27246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the ratio of cyclic nucleotide phosphodiesterase forms in the thymocytes of irradiated mice].
    Rybalkin SD; Sobolev AS
    Radiobiologiia; 1986; 26(2):167-70. PubMed ID: 3010370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine.
    Thompson WJ; Ross CP; Hersh EM; Epstein PM; Strada SJ
    J Cyclic Nucleotide Res; 1980; 6(1):25-36. PubMed ID: 6155390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN; Bobruskin ID; Severin SE
    Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
    Ilien B; Landry Y
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of cyclic nucleotide phosphodiesterase forms by serum and insulin in cultured fibroblasts.
    Pledger WJ; Thompson WJ; Epstein PM; Strada SJ
    J Cell Physiol; 1979 Sep; 100(3):497-507. PubMed ID: 226555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
    Davis CW; Daly JW
    Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
    [No Abstract]   [Full Text] [Related]  

  • 19. A simple direct assay of 3',5'-cyclic nucleotide phosphodiesterase activity based on the use of polyacrylamide-bononate affinity gel chromatography.
    Davis CW; Daly JW
    J Cyclic Nucleotide Res; 1979; 5(1):65-74. PubMed ID: 220290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells.
    Epstein PM; Mills JS; Ross CP; Strada SJ; Hersh EM; Thompson WJ
    Cancer Res; 1977 Nov; 37(11):4016-23. PubMed ID: 198126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.